Article Details
Retrieved on: 2021-05-17 05:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities raised Bristol-Myers Squibb from a "hold" rating to a "buy" rating and boosted their price objective for the company from $66.00 to ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here